To evaluate BC-PDE viability, mIF staining of FFPE sections using markers for proliferation (Ki67) and apoptosis (cPARP) was performed with a pan-cytokeratin marker (AE1/3) being used to distinguish tumour areas and DAPI for cell nuclei23,25. Here, SLC4A1 is linked to breast cancer.